D-1044-2017 Class II Terminated
FDA drug recall D-1044-2017 was initiated by Bayer HealthCare Pharmaceuticals, Inc. on Mar 30, 2017 and is designated Class II. Reason for recall: Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs. The recall status is terminated (terminated Jan 8, 2020). Affected quantity: 1,067,520 12-count cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 9, 2017
- Initiation Date
- Mar 30, 2017
- Termination Date
- Jan 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,067,520 12-count cartons
Product description
Alka-Seltzer Original ( 325 mg Aspirin (NSAID), 1916 mg Analgesic, Sodium bicarbonate/Antacid, 1000 mg Anhydrous Citric Acid) Effervescent Tablets, 12-count carton, Made in Germany, Distributed by Bayer HealthCare, LLC Whippany, NJ 07981, UPC 016500040194
Reason for recall
Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.
Distribution pattern
Nationwide
Code information
BTAH340; Exp. 02/19 BTAHCP0; Exp. 04/19 BTAHLW0; Exp. 06/19 BTAHLX0; Exp. 08/19 BTAHP10; Exp 08/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1044-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026